Literature DB >> 3880753

Giant axonal neuropathy: a conditional mutation affecting cytoskeletal organization.

M W Klymkowsky, D J Plummer.   

Abstract

Giant axonal neuropathy (GAN) results from autosomal recessive mutations (gan-) that affect cytoskeletal organization; specifically, intermediate filaments (IFs) are found collapsed into massive bundles in a variety of different cell types. We studied the gan- fibroblast lines WG321 and WG139 derived from different GAN patients. Although previous studies implied that the gan- IF phenotype was constitutive, we find that it is conditional. That is, when cells were grown under the permissive condition of medium containing over 2% fetal calf serum, most cells had normal IF organization. IF bundles formed when gan- cells were transferred to the nonpermissive condition of low (0.1%) serum. Microtubule organization appeared normal in the presence or absence of serum. The effect of serum starvation was largely blocked or reversed by the addition of BSA to the culture media. We found no evidence that the gan- phenotype depends upon progress through the cell cycle. We discuss the possible role of serum effects in the etiology of GAN and speculate as to the molecular nature of the gan- defect.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3880753      PMCID: PMC2113460          DOI: 10.1083/jcb.100.1.245

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  48 in total

1.  Peripheral nervous system in a case of canine giant axonal neuropathy.

Authors:  I D Duncan; I R Griffiths
Journal:  Neuropathol Appl Neurobiol       Date:  1979 Jan-Feb       Impact factor: 8.090

2.  Identification of a gene for alpha-tubulin in Aspergillus nidulans.

Authors:  N R Morris; M H Lai; C E Oakley
Journal:  Cell       Date:  1979-02       Impact factor: 41.582

3.  Retrograde axonal transport of endogenous proteins in sciatic nerve demonstrated by covalent labeling in vivo.

Authors:  D J Fink; H Gainer
Journal:  Science       Date:  1980-04-18       Impact factor: 47.728

4.  Intermediate filaments of the vimentin-type and the cytokeratin-type are distributed differently during mitosis.

Authors:  J E Aubin; M Osborn; W W Franke; K Weber
Journal:  Exp Cell Res       Date:  1980-09       Impact factor: 3.905

5.  Giant axonal neuropathy: intermediate filament aggregates in cultured skin fibroblasts.

Authors:  S D Pena
Journal:  Neurology       Date:  1981-11       Impact factor: 9.910

6.  CHO mutants resistant to colchicine, colcemid or griseofulvin have an altered beta-tubulin.

Authors:  F Cabral; M E Sobel; M M Gottesman
Journal:  Cell       Date:  1980-05       Impact factor: 41.582

7.  Mutation in a structural gene for a beta-tubulin specific to testis in Drosophila melanogaster.

Authors:  K J Kemphues; R A Raff; T C Kaufman; E C Raff
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

8.  Giant axonal neuropathy: visual and oculomotor deficits.

Authors:  T H Kirkham; D Guitton; S G Coupland
Journal:  Can J Neurol Sci       Date:  1980-08       Impact factor: 2.104

9.  Mutation in a testis-specific beta-tubulin in Drosophila: analysis of its effects on meiosis and map location of the gene.

Authors:  K J Kemphues; E C Raff; R A Raff; T C Kaufman
Journal:  Cell       Date:  1980-09       Impact factor: 41.582

10.  Intermediate filaments in nervous tissues.

Authors:  R K Liem; S H Yen; G D Salomon; M L Shelanski
Journal:  J Cell Biol       Date:  1978-12       Impact factor: 10.539

View more
  13 in total

1.  Onset of human cytomegalovirus replication in fibroblasts requires the presence of an intact vimentin cytoskeleton.

Authors:  Matthew S Miller; Laura Hertel
Journal:  J Virol       Date:  2009-04-29       Impact factor: 5.103

Review 2.  Intermediate filaments as dynamic structures.

Authors:  M W Klymkowsky
Journal:  Cancer Metastasis Rev       Date:  1996-12       Impact factor: 9.264

3.  Abnormal organization of keratin intermediate filaments in cultured keratinocytes of epidermolysis bullosa simplex.

Authors:  Y Kitajima; S Inoue; H Yaoita
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

4.  Formation of GFAP cytoplasmic inclusions in astrocytes and their disaggregation by alphaB-crystallin.

Authors:  Y Koyama; J E Goldman
Journal:  Am J Pathol       Date:  1999-05       Impact factor: 4.307

5.  Giant axonal neuropathy (GAN): an immunohistochemical and ultrastructural study report of a Latin American case.

Authors:  A L Taratuto; G Sevlever; M Saccoliti; L Caceres; M Schultz
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

6.  Giant axonal neuropathy-associated gigaxonin mutations impair intermediate filament protein degradation.

Authors:  Saleemulla Mahammad; S N Prasanna Murthy; Alessandro Didonna; Boris Grin; Eitan Israeli; Rodolphe Perrot; Pascale Bomont; Jean-Pierre Julien; Edward Kuczmarski; Puneet Opal; Robert D Goldman
Journal:  J Clin Invest       Date:  2013-04-15       Impact factor: 14.808

7.  Giant axonal neuropathy. A neuropathological study.

Authors:  H A Kretzschmar; B O Berg; R L Davis
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

8.  Giant axonal neuropathy: a rare inherited neuropathy with simple clinical clues.

Authors:  Mahesh Kamate; Shashikala Ramakrishna; Shweta Kambali; Anita Mahadevan
Journal:  BMJ Case Rep       Date:  2014-09-12

9.  Gigaxonin controls vimentin organization through a tubulin chaperone-independent pathway.

Authors:  Don W Cleveland; Koji Yamanaka; Pascale Bomont
Journal:  Hum Mol Genet       Date:  2009-01-24       Impact factor: 6.150

10.  Alterations in lipid metabolism gene expression and abnormal lipid accumulation in fibroblast explants from giant axonal neuropathy patients.

Authors:  Conrad L Leung; Yinghua Pang; Chang Shu; Dmitry Goryunov; Ronald K H Liem
Journal:  BMC Genet       Date:  2007-03-01       Impact factor: 2.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.